GMAB(Genmab A/S) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2017-12-31 | FY 截至 2018-12-31 | FY 截至 2019-12-31 |
|---|---|---|---|
| 营业收入 | $361.43M | $478.50M | $804.44M |
| 毛利润 | — | — | — |
| 营业利润 | $205.40M | $218.29M | $395.47M |
| 净利润 | $168.72M | $232.84M | $324.71M |
| 经营现金流 | $242.84M | $160.55M | $198.79M |
| 自由现金流 | $229.24M | $149.16M | $186.94M |
| 摊薄每股收益 | $2.72 | $3.75 | $5.10 |